Vigilare Wealth Management Athenex, Inc. Transaction History

Vigilare Wealth Management

  • $226 Million
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Jan 14, 2021
SELL
$11.06 - $14.01 $110,600 - $140,100
-10,000 Closed
0 $0
Q3 2020

Oct 15, 2020
BUY
$10.26 - $14.55 $102,600 - $145,500
10,000 New
10,000 $121,000
Q2 2020

Jul 20, 2020
SELL
$7.11 - $13.76 $91,008 - $176,128
-12,800 Closed
0 $0
Q1 2020

May 04, 2020
BUY
$5.71 - $15.85 $73,088 - $202,880
12,800 New
12,800 $99,000

Others Institutions Holding ATNX

# of Institutions
3
Shares Held
1.46M
Call Options Held
0
Put Options Held
0
View Full List

About Athenex, Inc.

ATNX Quotes by TradingView
  • Ticker ATNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 156,790,000
  • Market Cap $1.57M
  • Description
  • Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...
More about ATNX
Track This Portfolio

Track Vigilare Wealth Management Portfolio

Follow Vigilare Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vigilare Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Vigilare Wealth Management with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email